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No Collateral Damage with MicroRNA Cancer Therapy
PAGE 1005
MicroRNAs (miRNAs) are a diverse class of regulatory RNAs that provide critical physiologic functions and are frequently
dysregulated in disease states. Abnormal miRNA function plays a particularly important role in cancer pathogenesis, with
many miRNAs exhibiting downregulation in tumors. In this study, Kota et al. demonstrate that a specific miRNA, miR-26a,
is frequently downregulated in hepatocellular carcinoma (HCC). Systemic delivery of this miRNA in a mouse model of HCC
selectively kills tumor cells without causing toxic effects in normal cells, affording dramatic protection from disease progres-
sion. These findings demonstrate the therapeutic potential of restoring miRNAs for the treatment of cancer.
Shedding Light on Retinoblastoma
PAGE 1018
Retinoblastoma is known to result frommutations in RB1, yet the cell of origin in
humans and the basis for its extreme sensitivity to RB1 mutations have been
unclear. Xu et al. show that retinoblastoma cells resemble early cone photore-
ceptors, and that oncogenic signaling proteins—includingMDM2 and N-Myc—
are normally expressed during human cone precursor maturation. Thus, their
findings suggest that cell type-specific circuitry sensitizes to the oncogenic
effects of RB1 mutations.
miRed in Metastasis
PAGE 1032
MicroRNAs have recently emerged as attractive putative regulators of metastasis because of their capacity to pleiotropically
repress numerous target genes. Here, Reinhardt et al. report that the human microRNA miR-31 inhibits multiple stages of
breast cancer metastasis, including local invasion, extravasation or initial survival at a distant site, and metastatic coloniza-
tion. This pleiotropy was achieved by coordinate repression of a cohort of prometastatic targets, including the small GTPase
RhoA. These findings carry significant implications regarding our understanding of the pathogenesis of metastatic disease.
Cancer Cells Ride the WAVE
PAGE 1047
While normal epithelial tissuesmaintain well-organized structures, epithelial cancers have generally lost this arrangement and
present a chaotic architecture. Here, Silva et al. show that Cyfip1, a subunit of the WAVE complex that regulates cytoskeletal
dynamics, is a putative invasion suppressor gene that is commonly deleted in human epithelial cancers. The study unveils
a connection between actin cytoskeletal dynamics and tumorigenesis through effects on tissue architecture and cell adhesion
and suggests that distortion of actin-remodeling events could generally promote invasive phenotypes.
Glycylation, a Modification on the Move
PAGE 1076
Microtubules aremodified by a set of unusual posttranslational modifications, including pol-
yglycylation. In this issue, Rogowski et al. describe the discovery and functional analysis of
a group of enzymes that catalyze tubulin polyglycylation, and they compare the enzymes’
activity in several organisms. Using Drosophila as model, the authors show that this modifi-
cation is essential for development and plays an important role in the maintenance of the
microtubule backbone structure in the sperm flagellum. Importantly, identification of a range
of polyglycylated proteins suggests that this modification could be widespread.
Trashing p62 Keeps a Lid on Cancer
PAGE 1062
Loss of the essential autophagy gene beclin1 occurs in human cancers and renders mice
tumor prone, suggesting that autophagy can suppress tumorigenesis. Now, Mathew
et al. provide insight into how autophagy can act in tumor suppression. The p62 protein functions to direct proteins to auto-
phagosomes, where it is itself degraded. In response to stress, autophagy-defective tumor cells fail to degrade p62, resulting
in preferential p62 accumulation, oxidative stress, altered gene expression, and enhanced tumorigenesis. Suppression of
oxidative stress or p62 accumulation prevented damage resulting from autophagy defects. Thus, autophagic degradation
of specific proteins such as p62 is a tumor suppression mechanism.Cell 137, June 12, 2009 ª2009 Elsevier Inc. 975
Gray Hair, a Sign of Maturity and Stress
PAGE 1088
Hair graying, a typical sign of aging in mammals, is caused by the loss of of mela-
nocyte stem cells (MSCs) with age. Inomata et al. now report that excessive geno-
toxic stress inmiceabrogates the renewal ofMSCsby triggering their differentiation
into pigment-producing melanocytes, rather than inducing their apoptosis or
senescence. Furthermore, the authors show that ATM, a DNA damage checkpoint
kinase, protects MSCs from differentiating and prevents hair graying.
RIP3 Flips the Switch for Necrosis
PAGE 1100 and PAGE 1112
The tumor necrosis factor a (TNF-a) family of cytokines induce apoptosis by activating a group of intracellular proteases,
namely caspases. This response can be switched to necrosis when caspase activity is inhibited, but the molecular pathway
that regulates necrotic cell death remains undefined. Now, He et al. identify a member of the receptor interactive protein
kinase family, RIP3, as a critical determinant for the cellular necrosis response to TNF-a, and further show that RIP3 knockout
animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model. In an accompanying study, Cho
et al. identify amolecular complex containing the protein kinase RIP1, known to be required for necrosis, andRIP3. They show
that RIP3 regulates necrosis-specific RIP1 phosphorylation and that RIP3-dependent necrosis is important for virus-induced
tissue necrosis and inflammation.
Jagged Kicks It Up a Notch in Angiogenesis
PAGE 1124
Notch signaling controls growth, differentiation, and patterning processes. In growing blood
vessels, the Notch ligand Delta-like 4 (Dll4) restricts sprouting behavior to selected endothelial
tip cells, which lead and guide new sprouts. Benedito et al. now show that another Notch ligand,
Jagged1, promotes sprouting by antagonizing Dll4-Notch signaling in certain endothelial cells ex-
pressing Fringe family glycosyltransferases. This work reveals that a balance between two Notch
ligands with opposing roles regulates sprouting angiogenesis and potentially other Notch-
controlled biological processes.
PrP Caught in Inappropriate Contact with Ubiquitin Ligase
PAGE 1136
Several heritable and transmissible neurodegenerative diseases are caused by aberrant metabolism of the prion protein (PrP).
While the mechanisms of disease transmission have been extensively studied, little is known about the pathways that cause
the cellular dysfunction and neurodegeneration. Chakrabarti andHegde now show that in some forms of disease, the normally
cell-surface PrP accesses the cytosol, where it interacts with and disrupts the function of the ubiquitin ligaseMahogunin. Lack
of Mahogunin can lead to neurodegeneration, suggesting that PrP mislocalization followed by inappropriate Mahogunin
sequestration can act as a mechanism of pathology in certain neurodegenerative diseases.
It’s Splitsville for Pain Receptors
PAGE 1148
How different opioid receptor subtypes regulate pain is unclear. It is generally considered that the delta and mu opioid recep-
tors (DOR and MOR, respectively) co-occur in subsets of pain fibers, where they coordinately regulate pain. Now, Scherrer
et al. demonstrate that the DOR andMOR are, in fact, expressed by different pain fiber populations. Furthermore, the authors
show that the segregatedMOR andDORdistribution is paralleled by a selective functional contribution of the two receptors to
the control of heat and mechanical pain, respectively. These results demonstrate that distinct pain modalities can be selec-
tively regulated through the targeting of the relevant pain fibers via DOR and MOR agonists.Cell 137, June 12, 2009 ª2009 Elsevier Inc. 977
